Updated: May 7
Our site investigator, Dr. Anja Lindén, has successfully defended her thesis titled 'Optimizing fluid therapy in the hemodynamically unstable patient'. Dr. Lindén's thesis work has primarily focused on the REDUSE project and has significantly contributed to the realization of the REDUSE trial.
The results of the REDUSE feasibility trial were published today in Critical Care. Read the full article here.
Today (May 6), the investigation team at Östersund Hospital initiated the inclusion of participants for the REDUSE Trial.
Today (February 28), our team members at Halland Hospital in Halmstad initiated the inclusion of participants for the REDUSE Trial.
Comments